Takashi Yagisawa 1,2*, Makiko Mieno 1,3, Norio Yoshimura 1,4, Kenji Yuzawa 1,5 and Shiro Takahara 1,6

Similar documents
Trends of kidney transplantation in Japan in 2018: data from the kidney transplant registry

Living Donor Paired Exchange (LDPE)

Transplantation in Australia and New Zealand

ABO. ABO ABO ABO ABO ABO ABO ABO ABO. Key words ABO. Alexandre ABO ABO. double filtration plasmapheresis, DFPP. antibody-mediated rejection, AMR

Annual Statistics on Organ Replacement in Canada

Effectiveness of the surgical torque limiter: a model comparing drill- and hand-based screw insertion into locking plates

A hemodialysis cohort study of protocolbased anticoagulation management

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

UCLA Kidney Exchange. An option for patients with incompatible living donors

Chapter 6: Transplantation

CT findings in patients with Cabazitaxel induced pelvic pain and haematuria: a case series

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Kidney and Pancreas Transplantation in the United States,

Torsion bottle, a very simple, reliable, and cheap tool for a basic scoliosis screening

Relationship between incident types and impact on patients in drug name errors: a correlational study

United States Renal Data System (USRDS) International Data Collection Form

Lars Jacobsson 1,2,3* and Jan Lexell 1,3,4

Pregabalin prescription for terminally ill cancer patients receiving specialist palliative care in an acute hospital

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

Long-term results of the first line DMT depend on the presence of minimal MS activity during first years of therapy: data of 15 years observation

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

Chapter 9. Kidney Donors. ANZDATA Registry 37th Annual Report. Data to 31-Dec-2013

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

The New Kidney Allocation Policy: Implications for Your Patients and Your Practice

For more information about how to cite these materials visit

Progress in Pediatric Kidney Transplantation

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

Living Kidney Donation. Dr. Joseph Keith Melancon

ABO-incompatible kidney transplantation in elderly patients over 60 years of age

NAPRTCS Annual Transplant Report

NAPRTCS Annual Transplant Report

BK virus infection in renal transplant recipients: single centre experience. Dr Wong Lok Yan Ivy

Kidney Transplant Activity New Zealand

Ligation of lymph vessels for the treatment of recurrent inguinal lymphoceles following lymphadenectomy

Kidney Transplant Activity New Zealand

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Table S1. Clinical outcomes of the acceptable mismatch allocation model.

Hong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver

Chapter 9. Kidney Donors. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

NHSBT Board July Update on UK Living Kidney Sharing Scheme

The New Kidney Allocation System: What You Need to Know. Anup Patel, MD Clinical Director Renal and Pancreas Transplant Division Barnabas Health

Current status of kidney and pancreas transplantation in the United States,

KIDNEY TRANSPLANT - A TREATMENT OPTION

Commonly Asked Questions about Kidney Transplants

Transplant Options for Patients: Choices and Consequences. Olwyn Johnston Medical Director Kidney Transplantation Vancouver General Hospital

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Management of End Stage Renal Disease-Bangladesh Perspective

A Guide to Better Living

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

Vol. 29, pp.585 ~ 589, ml. 1.6 mg/dl 1 MRSA. Table 1 MRI

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

Kidney Transplant Outcomes for Prolonged Cold Ischemic Times in the Context of Kidney Paired Donation

chapter seven transplantation page

CHAPTER 5 RENAL TRANSPLANTATION

Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients

Chapter 7. Australian Waiting List. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Answers to Your Questions about a Change in Kidney Allocation Policy What you need to know

NAPRTCS Annual Report

The updated incidences and mortalities of major cancers in China, 2011

Subdural hemorrhages in acute lymphoblastic leukemia: case report and literature review

About kidney transplant care in New Zealand

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Organ Procurement and Transplantation Network

Is a kidney transplant right for me?

Access and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival

The most important question in family approach: the potential of the resolve item of the family APGAR in family medicine

TA L K I N G A B O U T T R A N S P L A N TAT I O N

Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients

New Zealand Kidney Allocation Scheme

Interruption of enteral nutrition in the intensive care unit: a single-center survey

39th SESSION OF THE SUBCOMMITTEE ON PLANNING AND PROGRAMMING OF THE EXECUTIVE COMMITTEE

2012 Year In Review In Review. Number of Patients on WaitList as of Number Of Transplants Year. Number Of Patients

NAPRTCS Annual Report

Oxford Transplant Centre. Live donor kidney transplantation what if we are not a match?

2014 Year End Review

USRDS UNITED STATES RENAL DATA SYSTEM

East of Scotland Renal Transplantation Service. Annual Report. The Royal Infirmary of Edinburgh

Supplementary appendix

KIDNEY FAILURE TREATMENT OPTIONS Choosing What s Best For You

Barriers to Transplantation

A practical approach of salt and protein restriction for CKD patients in Japan

Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Wang, H; Jiang, W; Zhou, Z; Long, J; Li, W; Fan, ST

The number of patients registered on the kidney transplant list this year fell by 4% from 5,233 to 5,033

Peter Chang,* Jagbir Gill,* James Dong,* Caren Rose,* Howard Yan,* David Landsberg,* Edward H. Cole, and John S. Gill*

Getting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:

QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room

Analysis of the Results of ABO-Incompatible Kidney Transplantation: In Comparison with ABO-Compatible Kidney Transplantation

Renal Transplant Registry Report 2008

Waiting for a Kidney. Objectives

NAPRTCS Annual Report

Antibody incompatible kidney transplantation from a deceased donor

New Ways to Tackle a Growing Health Care Dilemma - ESRD

Transplant Hepatology

Regulatory Innovation: Not an Oxy-Moron. Alexandra K Glazier, Esq. President & CEO New England Donor Services

Welcome to Transplantation

CHAPTER 5 RENAL TRANSPLANTATION. Editor: Dr Goh Bak Leong

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

Transcription:

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 DOI 10.1186/s41100-016-0080-9 POSITION STATEMENT Current status of kidney transplantation in Japan in 2015: the data of the Kidney Transplant Registry Committee, Japanese Society for Clinical Renal Transplantation and the Japan Society for Transplantation Takashi Yagisawa 1,2*, Makiko Mieno 1,3, Norio Yoshimura 1,4, Kenji Yuzawa 1,5 and Shiro Takahara 1,6 Abstract Open Access The first deceased and living donor kidney transplants were performed in 1956 and 1964 in Japan, respectively. Larger numbers of transplants were performed after the introduction of cyclosporine in 1983. After that, the number has gradually and steadily increased and 1661 transplants were performed in 2015. In addition, the outcomes have improved year by year. The indications for transplantation have also expanded in various aspects, such as recipient and donor age, primary diseases, ABO incompatible and highly sensitized cases, and preemptive transplant. We here report the current status of kidney transplantation in Japan. The number of transplants, detail transplant characteristics in the past decade, and outcomes are described. Keywords: Kidney transplantation, Japan Introduction The first deceased and living donor kidney transplants were performed in 1956 and 1964 in Japan, respectively. The number of transplants gradually increased year by year. Larger numbers of transplants were performed after the introduction of cyclosporine in 1983. The first ABO incompatible transplant, which is now widely performed in Japan, was done in 1989. Afterward, as tacrolimus and mycophenolate mofetil became available, the number of transplants moreover increased and reached more than 1000 in 2006. The number has steadily increased in the 2000s. We report the current status of kidney transplantation in Japan. The number of transplants performed in Japan from 2001, detail transplant characteristics from 2007, and outcomes are described. This report is based on the data of annual progress report from the Japanese Renal * Correspondence: yagisawa@jichi.ac.jp 1 The Kidney Transplant Registry Committee, Japanese Society for Clinical Renal Transplantation and the Japan Society for Transplantation, Osaka, Japan 2 Department of Urology, Division of Renal Surgery and Transplantation, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-city, Tochigi 329-0498, Japan Full list of author information is available at the end of the article Transplant Registry from 2007 to 2015 published in Japanese Journal Ishoku [1 14]. All individual data were collected from the kidney transplant centers in Japan. Total kidney transplants and transplant centers In 2001, a total of 705 transplants, including 554 from living donors and 151 from deceased donors, were performed. The number gradually increased and reached 1000 in 2006 and 1500 in 2011. Afterward, approximately 1600 transplants were done every year, and 1661 transplants were performed in 2015, which was the largest number so far. While the number of living donor transplants has increased, that of deceased donor transplants has not changed since 2001 (Fig. 1). Living donor transplants accounted for 83 to 90% of all transplants in the past decade, and the rate of living donor transplants has been increasing. A total of 120 to 140 centers have performed kidney transplants since 2001. About 40% of the centers performed only 1 to 4 cases a year in 2015. About 20 centers have routinely performed more than 20 cases a year (Fig. 2). The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 2 of 7 Fig. 1 Total kidney transplants Transplant characteristics A) Reoccurrence of transplantation (Fig. 3) Approximately 95% of living donor transplants and 90% of deceased donor transplants were the first time transplants. The rates of the 2nd and more than 3rd transplants were about 3 to 4% in living donor and 6 to 10% in deceased donor cases, respectively. However, the rate of re-transplants decreased to 2.6% in deceased donor cases in 2015. B) Age (Figs. 4 and 5) Mean age of living donor transplants increased year by year, such as 42.8 years in 2007 and 47.0 years in 2 015. On the other hand, mean age of deceased donor transplants was unchanged, such as 47.0 years in 2001 and 48.0 in 2015 (Fig. 4). The number of transplants by age (10-year intervals) is shown in Fig. 5. In living donor transplants, the number aged 40 to 49 and 60 to 69 years has rapidly increased since 2007. In addition, the number aged 70 to 79 years increased in these recent 3 years. In deceased donor transplants, the number aged 50 to 59, 40 to 49, and 60 to 69 years was large and these transplants occupied about 80% of all. C) Sex (Fig. 6) In both living donor and deceased donor transplants, 60 to 65% of transplants were male over the past decade. The rate of males has gradually decreased in deceased donor transplants since 2012. D) Primary disease (Fig. 7) Fig. 3 Times of transplantation In 2007, glomerulonephritis was a primary diagnosis for about 60% of transplants, diabetes for 17%, and polycystic kidney diseases for 9%. The number of diabetes as a primary disease has increased afterward, and 24% of transplants were diabetes in 2015. The rate of glomerulonephritis was about 46% in 2015. E) Dialysis therapy before transplantation (Figs. 8, 9, 10, 11, and 12) Figure 8 demonstrates the rates of preemptive transplants and transplants after dialysis therapy. The proportion of preemptive and temporary Fig. 2 Kidney transplant centers Fig. 4 Mean age of kidney transplants

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 3 of 7 Fig. 7 Kidney transplants, by primary diseases (%) Fig. 5 Kidney transplants from living and deceased donors, by age (# cases) dialysis transplants has increased year by year and was approximately 34% in 2015. Mean dialysis periods prior to transplantation in living and deceased donor transplants with chronic dialysis therapy are shown in Fig. 9. The periods were 3 to 4 years in living donor transplants and 14 to 17 years in deceased donor transplants in the past decade. There was a big difference between living and deceased donor transplants during the dialysis Fig. 8 Dialysis therapy prior to transplantation Fig. 9 Mean dialysis periods prior to transplantation Fig. 6 Kidney transplants, by sex (%) Fig. 10 Living donor transplants, by dialysis periods (# cases)

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 4 of 7 Fig. 11 Deceased donor transplants, by dialysis periods (# cases) period. As the length of the waiting time is a major factor for candidate selection for deceased donor transplant in Japan, the patient with a longer period of dialysis therapy is frequently selected as the candidate. Figures 10 and 11 show the number of transplants by dialysis period in living and deceased donor transplants, respectively. In living donor transplants, the number of preemptive transplants has rapidly increased and is the biggest, followed by those of 1 to 3 years, within 1 month (temporary dialysis), 1 to 6 months, and 6 months to 1 year dialysis Fig. 13 ABO incompatible kidney transplants (# cases) therapy in 2015. On the other hand, the number of transplants with more than 20 years dialysis therapy is the biggest, followed by 15 to 20 years and 10 to 15 years dialysis therapy in deceased donor transplants. Regarding the modality of dialysis therapy, about 85% was hemodialysis and 10% was peritoneal dialysis in the past decade (Fig. 12). F) ABO blood type compatibility (Figs. 13 and 14) The first ABO incompatible living transplant was performed in 1989 in Japan. The number has increased, especially since 2002 and continues to increase year by year. In 2015, 411 ABO incompatible living transplants were performed, which was 32.7% of living donor transplants. No ABO incompatible deceased donor transplant has been performed in the past decade. Kidney donor In the past decade, 83 to 90% of kidney donors were living and the rate of living donor has been increasing. Mean age of living donors gradually increased and that of deceased donors decreased in these 3 years (Fig. 15). The number of living donors aged 60 to 69 and 70 to 79 years has increased in the past decade. Most deceased donors were 40 to 69 years old (Fig. 16). The rate of male was about 40% in living donors, while 60% in deceased donors (Fig. 17). Fig. 12 Modality of dialysis therapy prior to transplantation Fig. 14 Living donor transplants, by ABO compatibility (%)

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 5 of 7 Fig. 15 Mean age of kidney donors Outcomes The patient and graft survivals analyzed at the time of May 2016 are shown in Figs. 18 and 19 and Table 1. The rates were analyzed using Kaplan-Meier method, stratified by the year of transplantation, such as 1956 to 1982, 1983 to 2000, 2001 to 2009, and 2010 to 2014. A) Patient survival The patient survival rates in both living and deceased donor transplants have improved since 1983 when cyclosporine became available. The rate has increased in order of the time of transplantation. For living and deceased donor transplants performed in 2010 to 2014, the rates were 99.1 and 97.8% in 1 year and 97.2 and 93.4% in 5 years, respectively (Fig. 18, Table 1). B) Graft survival The graft survival rates have also improved remarkably in both living and deceased donor transplants in order of the time of transplantation. Fig. 17 Kidney donors, by sex (%) Fig. 16 Living and deceased kidney donors, by age (# cases) Fig. 18 Patient survival

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 6 of 7 Table 1 Patient and graft survivals # analyzed 1 year 5 years 10 years 15 years Patient survival Living 1956~1982 1478 83.1 [1.0] 71.2 [1.2] 63.6 [1.3] 58.3 [1.3] 1983~2000 7365 97.0 [0.2] 93.4 [0.3] 88.6 [0.4] 84.1 [0.5] 2001~2009 6820 98.3 [0.2] 96.0 [0.2] 92.7 [0.4] 2010~2014 5156 99.1 [0.1] 97.2 [0.4] Deceased 1956~1982 322 66.4 [2.7] 55.0 [2.9] 46.6 [2.9] 40.7 [2.9] 1983~2000 2796 92.4 [0.5] 85.6 [0.7] 78.5 [0.8] 70.6 [0.9] 2001~2009 1323 95.9 [0.5] 89.2 [0.9] 80.8 [1.4] 2010~2014 673 97.8 [0.6] 93.4 [1.4] Graft survival Living 1956~1982 1230 73.6 [1.3] 53.9 [1.4] 40.2 [1.4] 32.3 [1.3] 1983~2000 5486 92.8 [0.3] 81.8 [0.5] 69.1 [0.6] 60.2 [0.7] 2001~2009 6141 97.5 [0.2] 93.6 [0.3] 87.0 [0.6] 2010~2014 4780 98.7 [0.2] 94.6 [0.6] Deceased 1956~1982 283 45.4 [3.0] 27.0 [2.6] 16.2 [2.2] 10.8 [1.9] 1983~2000 2253 81.4 [0.8] 64.4 [1.0] 51.4 [1.1] 41.8 [1.1] 2001~2009 1151 92.4 [0.8] 83.4 [1.1] 71.1 [1.8] 2010~2014 617 96.4 [0.7] 87.5 [2.0] The rates for living donor transplants performed in 2001 to 2009 were 97.5% in 1 year, 93.6% in 5 years, and 87.0% in 10 years. Those for deceased donor transplants were 92.4% in 1 year, 83.4% in 5 years, and 71.1% in 10 years. The rates improved furthermore in transplants performed in 2010 to 2014. The rate for living ones was higher than that for deceased ones in all stratifications (Fig. 19,Table1). Summary and conclusion The number of kidney transplants has increased gradually and steadily in Japan. In addition, the outcomes have improved year by year. The indications for kidney transplantation have also expanded in various aspects, such as recipient and donor age, primary diseases, ABO incompatible and highly sensitized cases, and preemptive transplant. Therefore, kidney transplantation is now an ideal treatment modality in patients with end-stage kidney disease who have living kidney donors in Japan. However, though the number of candidates on the kidney transplant waiting list is nearly 13,000, that of deceased donors is very small and only 167 deceased donors kidney transplants are Fig. 19 Graft survival performed in 2015. Effort to increase deceased donor kidney donations primarily continues to be needed for development of kidney transplantation in Japan. Acknowledgements Not applicable. Funding Not applicable. Availability of data and materials Please contact the author for data requests. Authors contributions Authors who are the members of the kidney transplant registry committee carried out the analyses of the data and approved the manuscript. Competing interests The authors declare that they have no competing interests. Consent for publication Not applicable. Ethics approval and consent to participate All registered data were approved by each transplant center. Author details 1 The Kidney Transplant Registry Committee, Japanese Society for Clinical Renal Transplantation and the Japan Society for Transplantation, Osaka, Japan. 2 Department of Urology, Division of Renal Surgery and Transplantation, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-city, Tochigi 329-0498, Japan. 3 Department of General Education, Division of Medical Information, Jichi

Yagisawa et al. Renal Replacement Therapy (2016) 2:68 Page 7 of 7 Medical University, Tochigi, Japan. 4 Department of Surgery, Division of Transplantation and general Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan. 5 Department of Transplant Surgery, Mito Medical Center, Mito, Japan. 6 Department of Advanced Technology for Transplantation, Graduate School of Medicine, Osaka University, Osaka, Japan. Received: 1 September 2016 Accepted: 3 November 2016 References 1. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2007 and follow-up survey -1 Jap J of Transplant. 2008;43:206 10. (in English). 2. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2007 and follow-up survey -2 Jap J of Transplant. 2008;43:448 57. (in English). 3. The Japan Society for Transplantation, Japanese Society for Clinical Transplant Registry: number of renal transplantation in 2008 and followup survey -1 Jap J of Transplant. 2009;44:250 55. (in English). 4. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2008 and follow-up survey -2 Jap J of Transplant. 2009;44:548 58. (in English). 5. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2009 and follow-up survey -1 Jap J of Transplant. 2010;45:237 42. (in English). 6. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2009 and follow-up survey -2 Jap J of Transplant. 2010;45:595 607. (in English). 7. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2009 and follow-up survey -3 Jap J of Transplant. 2010;45:608 20. (in English). 8. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2010 and follow-up survey -1 Jap J of Transplant. 2011;46:313 18. (in English). 9. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2010 and follow-up survey -2 Jap J of Transplant. 2011;46:506 23. 2011;46:506 23. (in English). 10. The Japan Society for Transplantation, Japanese Society for Clinical Transplant Registry: number of renal transplantation in 2011 and follow-up survey Jap J of Transplant. 2012;47:400 15. (in English). 11. The Japan Society for Transplantation, Japanese Society for Clinical Transplant Registry: number of renal transplantation in 2012 and follow-up survey Jap J of Transplant. 2013;48:347 61. (in English). 12. The Japan Society for Transplantation, Japanese Society for Clinical Transplant Registry: number of renal transplantation in 2013 and follow-up survey Jap J of Transplant. 2014;49:240 60. (in English). 13. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2014 and follow-up survey Jap J of Transplant. 2015;50:101 18. (in English). 14. The Japan Society for Transplantation, Japanese Society for Clinical Renal Registry: number of renal transplantation in 2015 and follow-up survey Jap J of Transplant. 2016;51:124 44. (in English). Submit your next manuscript to BioMed Central and we will help you at every step: We accept pre-submission inquiries Our selector tool helps you to find the most relevant journal We provide round the clock customer support Convenient online submission Thorough peer review Inclusion in PubMed and all major indexing services Maximum visibility for your research Submit your manuscript at www.biomedcentral.com/submit